230 related articles for article (PubMed ID: 16817769)
1. Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.
Le Guillou-Guillemette H; Renier G; Vielle B; Abgueguen P; Chennebault JM; Lunel F; Payan C
Viral Immunol; 2006; 19(2):267-76. PubMed ID: 16817769
[TBL] [Abstract][Full Text] [Related]
2. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
3. Central memory CD4 T cells are associated with incomplete restoration of the CD4 T cell pool after treatment-induced long-term undetectable HIV viraemia.
Rallón N; Sempere-Ortells JM; Soriano V; Benito JM
J Antimicrob Chemother; 2013 Nov; 68(11):2616-25. PubMed ID: 23833186
[TBL] [Abstract][Full Text] [Related]
4. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection.
Hejdeman B; Lenkei R; Leandersson AC; Hultström AL; Wahren B; Sandström E; Bratt G
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):277-86. PubMed ID: 11242515
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis A vaccination and immunological parameters in HIV-infected patients.
Kourkounti S; Papaizos V; Leuow K; Kordosis T; Antoniou C
Viral Immunol; 2013 Oct; 26(5):357-63. PubMed ID: 24044625
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF; Price P; French MA
HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
[TBL] [Abstract][Full Text] [Related]
8. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
[TBL] [Abstract][Full Text] [Related]
9. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
[TBL] [Abstract][Full Text] [Related]
10. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
Powles T; Imami N; Nelson M; Gazzard BG; Bower M
AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
[TBL] [Abstract][Full Text] [Related]
12. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
Guadalupe M; Reay E; Sankaran S; Prindiville T; Flamm J; McNeil A; Dandekar S
J Virol; 2003 Nov; 77(21):11708-17. PubMed ID: 14557656
[TBL] [Abstract][Full Text] [Related]
13. Thymic function in HIV-infection.
Kolte L
Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
[TBL] [Abstract][Full Text] [Related]
14. [The reconstitutional profiles of peripheral blood natural killer cell, gammadelta T lymphocyte and CD(4)(+)T cell in human immunodeficiency virus infected patients during one-year antiretroviral therapy].
Xie J; Qiu ZF; Han Y
Zhonghua Nei Ke Za Zhi; 2008 Sep; 47(9):750-3. PubMed ID: 19080202
[TBL] [Abstract][Full Text] [Related]
15. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection.
Lange CG; Valdez H; Medvik K; Asaad R; Lederman MM
Clin Immunol; 2002 Feb; 102(2):154-61. PubMed ID: 11846457
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
19. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R
Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290
[TBL] [Abstract][Full Text] [Related]
20. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
